Donatello Gemma

Activity and Safety of Cetuximab Plus Modified FOLFOXIRI Followed by Maintenance With Cetuximab or Bevacizumab for <i>RAS</i> and <i>BRAF</i> Wild-type Metastatic Colorectal Cancer

Chiara Cremolini, Carlotta Antoniotti, Sara Lonardi et al. · JAMA Oncology · 2018 · 111 citations · Full text

Phase II randomised study of maintenance treatment with bevacizumab or bevacizumab plus metronomic chemotherapy after first-line induction with FOLFOXIRI plus Bevacizumab for metastatic colorectal cancer patients: the MOMA trial

Chiara Cremolini, Federica Marmorino, Francesca Bergamo et al. · European Journal of Cancer · 2019 · 32 citations

Surgical Oncology, Phase Ii, First-line Induction +8

Treatment of Metastatic Colorectal Cancer Patients ≥75 Years Old in Clinical Practice: A Multicenter Analysis

Roberta Grande, Clara Natoli, F. Ciancola et al. · PLoS ONE · 2016 · 22 citations · Full text

Symptom improvement as prognostic factor for survival in cancer patients undergoing palliative care: a pilot study

Filomena Narducci, Roberta Grande, Lucia Mentuccia et al. · Supportive Care in Cancer · 2011 · 19 citations

Palliative Care, Nursing, Hospice +8

Pre-emptive skin toxicity treatment for anti-EGFR drugs: evaluation of efficacy of skin moisturizers and lymecycline. A phase II study

Roberta Grande, Filomena Narducci, Sara Bianchetti et al. · Supportive Care in Cancer · 2013 · 17 citations

Medicine, Cutaneous Biology, Phase Ii Study +7